PTAB challenges

As a senior PTAB practitioner analyzing US patent 12,377,343, my assessment is based on the provided internal records and a comprehensive search of public dockets.

Proceedings Overview

There are no PTAB AIA trial proceedings on file for US patent 12,377,343. A defendant facing this patent would have a full range of prior-art-based invalidity arguments available for a potential IPR, as no claims have been previously challenged or validated at the PTAB.

(No proceedings on file)

• Type: N/A
• Filed: N/A
• Status: N/A
• Judge panel: N/A
• Petition grounds: N/A
• Institution decision: N/A
• Final Written Decision: N/A
• Settlement / termination: N/A
• Appeal: N/A
• Defensive value: The patent is entirely untested at the PTAB. This presents both an opportunity and a risk for a defendant. The opportunity is that all invalidity grounds based on patents and printed publications are available. The risk is that there is no established record of the patent owner's litigation or defense strategy before the Board, and no claims have been weakened or narrowed by a previous challenge.

Strategic Summary

All claims of US patent 12,377,343 remain untested in any AIA trial proceeding. Consequently, all 28 granted claims are currently sustained, and a defendant must consider them all to be presumptively valid.

The estoppel landscape is completely open. Since no inter partes review has been filed, let alone instituted, the § 315(e)(2) estoppel provisions do not apply. A potential defendant is free to petition for IPR on any grounds based on prior art patents or printed publications that could be raised under 35 U.S.C. §§ 102 and 103.

There are no pattern signals to analyze. The patent owner, Hong Kong Zhan Teng Jiada Technology Ltd, and the original assignee, Shenzhen Shi Hu Lian Heng Tong Trading Co Ltd, do not have a history of PTAB litigation that would indicate their likely response to a petition. The absence of any challenges from defensive aggregators like Unified Patents suggests the patent has not been widely asserted, or at least not against entities that typically fund such defensive actions.

Recommended Next Steps

For a defendant currently facing an assertion of US patent 12,377,343, the immediate path is clear:

• Conduct a Thorough Prior Art Search: Given that no PTAB proceedings exist, the first and most critical step is to commission a comprehensive validity search. The goal is to identify strong prior art patents and printed publications that could form the basis of an IPR petition.
• Evaluate IPR as a Defensive Lever: An IPR provides a cost-effective and often faster alternative to district court litigation for resolving validity disputes. The complete absence of a PTAB record for this patent means that a well-crafted petition has the potential to be the first test of the patent's strength against a motivated challenger.
• No Precedent to Overcome: Without prior FWDs or institution decisions, there are no unfavorable claim constructions or arguments from the patent owner that a petitioner would need to overcome. A petitioner would have a clean slate to present their invalidity case to the PTAB.

In summary, the lack of PTAB activity for US patent 12,377,343 is a significant strategic data point. It indicates the patent is "unhardened" by post-grant challenges and that a full range of defensive options, particularly the filing of an IPR, remains available to an accused infringer.